Chetan Nandecha has extensive experience in regulatory affairs, beginning with a role as a Research Scientist at Ranbaxy from June 2009 to February 2012, where responsibilities included regulatory compliance. Chetan transitioned to Novartis, serving in various capacities in Regulatory CMC from September 2016 to March 2019, including Associate Manager I&II and Senior Manager, eventually rising to Associate Director. Currently, Chetan holds the position of Director - Regulatory CMC at AstraZeneca, starting in April 2024.
This person is not in the org chart
This person is not in any teams
This person is not in any offices